NNM Securities
ABOUT US
SERVICES
EQUITY
COMMODITY
CURRENCY
DERIVATIVES
MUTUAL FUND
ADVISORY
FINANCING
MARKET INFO
EQUITY
DERIVATIVES
IPO
MUTUAL FUNDS
CURRENCY
COMMODITIES
RESEARCH
CONTACT US
LOGIN
Gallery
Open Account Meon
Open Account
Partner Us
Downloads
COMPANY
EQUITY
DERIVATIVES
IPO
MUTUAL FUNDS
CURRENCY
COMMODITIES
more from company profile
General
Smart Quotes
Company Information
Comparison
Company News
Financials
Balance Sheet
Profit & Loss
Quarterly Results
Financial Ratios
Cash Flow
Holdings
Share Holdings
MF Holdings
Digital Reports
Corp Actions
Board Meeting
Book Closure
Bonus Issues
Dividend Details
Price Info
Share Price
Historical Volume
Deliverable Volume
Bulk Deals
Block Deals
Price Charts
Home
Market Info
Company Profile
Smart Quotes
Smart Quotes
GLAXOSMITHKLINE CONSUMER HEALTHCARE LTD. - (AMALGAMATED)
NSE :
NA
BSE :
500676
ISIN CODE :
INE264A01014
Industry :
Consumer Food
House :
Glaxosmithkline - MNC
BSE
10753.65
0 (0 %)
PREV CLOSE (
)
10753.65
OPEN PRICE (
)
10500.00
BID PRICE (QTY)
0.00 (0)
OFFER PRICE (QTY)
0.00 (0)
VOLUME
2533
TODAY'S LOW / HIGH (
)
10394.05
10845.75
52 WK LOW / HIGH (
)
10394.05
10845.75
NSE
This Company is not listed in NSE
BSE
1D
1M
3M
1Y
3Y
5Y
STOCK SUMMARY
Incorporation Year :
30-10 1958
Management Info
P Dwarakanath - Chairman
Navneet Saluja - Managing Director
Registered Office
Address
Patiala Road,,,
Nabha,
Punjab-147201
Phone
Email
investor.2.co@gsk.com.
Website
www.gsk-ch.in
Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing :
BSE, NSE
NEWS
15
Dec
Glaxosmithkline Pharmaceuticals inform
Pursuant to Regulation 39 and other application regulations of SEBI (Lis..
19
Mar
GlaxosmithKline Consumer Healthcare in
Pursuant to Regulation 39 of SEBI (Listing Obligations and Disclosure Re..
13
Mar
GlaxosmithKline Consumer Healthcare in
Pursuant to Regulation 39 of SEBI (Listing Obligations and Disclosure Re..
29
Jan
GlaxoSmithKline Consumer Healthcare in
Pursuant to Regulation 39 of SEBI (Listing Obligations and Disclosure Re..
07
Nov
GlaxoSmithKline Consumer Healthcare in
GlaxoSmithKline Consumer Healthcare has informed that pursuant to Regula..
MORE
X
Financials
Rs.
in Millions
QTR Dec 19
ANNUAL 19
Net Profit
2766.3
9828
Gross Profit
3674.6
15122.9
Operating Profit
3881.2
15735.7
Net Sales
11588.6
47820.1
MORE
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
Bonus Issues
Book Closure
Board Meeting
peer group
Vadilal Industries (
BSE
)
 4530.00
(5.86%)
M.Cap (
Rs.
in Cr)
3256.09
Nestle (
BSE
)
 2562.70
(2.39%)
M.Cap (
Rs.
in Cr)
247084.56
Vadilal Enterprise (
BSE
)
 3990.00
(0.63%)
M.Cap (
Rs.
in Cr)
344.20
Zydus Wellness (
BSE
)
 1673.00
(1.43%)
M.Cap (
Rs.
in Cr)
10645.66
Sheetal Cool Prod (
BSE
)
 422.90
(2.09%)
M.Cap (
Rs.
in Cr)
444.05
MORE
Shareholding Pattern
PROMOTERS
72.46%
NON-INSTITUTION
16.4%
MUTUAL FUNDS/UTI
3.68%
FI/BANKS/INSURANCE
2.88%
GOVERNMENT
0%
FII
0%
MORE
Mf Holdings
Scheme Name
Hold(%)
No Data Found
MORE